Warning Letters Issued by the FDA Regarding Cannabinoid Products

Warning Letters Issued by the FDA Regarding Cannabinoid Products

As part of the FDA’s efforts to protect consumers from health fraud, warning letters have been issued to dispensing companies for:

  • Illegally selling products online that claim to prevent, diagnose, treat, or cure diseases without FDA approval
  • Misbranding or mislabeling products, including products that the FDA tested and found that they did not have the cannabinoid content that was specified on the label